Mutated G-protein-coupled receptor GPR10 is responsible for the hyperphagia/dyslipidaemia/obesity locus of Dmo1 in the OLETF rat

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 5-6, 2005, Pages 355-366

  Watanabe, Takeshi K ^a   Suzuki, Mikio ^a   Yamasaki, Yuki ^a   Okuno, Shiro ^a   Hishigaki, Haretsugu ^a   Ono, Toshihide ^a   Oga, Keiko ^a   Mizoguchi Miyakita, Ayako ^a   Tsuji, Atsushi ^b   Kanemoto, Naohide ^a   Wakitani, Shigeyuki ^c   Takagi, Toshihisa ^d   Nakamura, Yusuke ^d   Tanigami, Akira ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Diabetes; Diabetes Mellitus OLETF type I (Dmo1); G protein coupled receptor 10 (GPR10); Hyperphagia; Obesity; Otsuka Long Evans Tokushima Fatty (OLETF) rat; Prolactin releasing peptide

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PROLACTIN RELEASING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CODON; DIABETES MELLITUS; DIET RESTRICTION; DYSLIPIDEMIA; FOOD INTAKE; GENE; GENE LOCUS; GENE MUTATION; GPR10 GENE G; HYPERPHAGIA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; QUANTITATIVE TRAIT LOCUS; RAT; RAT STRAIN; SEGREGATION ANALYSIS; TRANSLATION INITIATION;

ANIMALS; BASE SEQUENCE; DYSLIPIDEMIAS; GENOTYPE; HYPERPHAGIA; MALE; MUTATION; OBESITY; QUANTITATIVE TRAIT LOCI; RATS; RATS, INBRED BN; RATS, INBRED OLETF; RECEPTORS, G-PROTEIN-COUPLED; SPECIES SPECIFICITY;

EID: 20344375263     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04196.x     Document Type: Article

References (39)

1. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 1992; 41: 1422-8.
2. Kanemoto N, Hishigaki H, Miyakita A et al. Genetic dissection of 'OLETF', a rat model for non-insulin-dependent diabetes mellitus. Mamm. Genome 1998; 9: 419-25.
3. Watanabe TK, Okuno S, Oga K et al. Genetic dissection of 'OLETF', a rat model for non-insulin-dependent diabetes mellitus: Quantitative trait locus analysis of (OLETF × BN) × OLETF. Genomics 1999; 58: 233-9.
4. Okuno S, Watanabe TK, Ono T et al. Genetic determinants of plasma triglyceide levels in (OLETF × BN) × OLETF backcross rats. Genomics 1999; 62: 350-5.
5. Yamasaki Y, Watanabe TK, Okuno S et al. Quantitative trait loci for lipid metabolism in the study of OLETF × (OLETF × Fischer 344) backcross rats. Clin. Exp. Pharmacol. Physiol. 2000; 27: 881-6.
6. Wei S, Wei K, Moralejo DH et al. Mapping and characterization of quantitative trait loci for non-insulin-dependent diabetes mellitus with an improved genetic map in the Otsuka Long-Evans Tokushima fatty rat. Mamm. Genome 1999; 10: 249-58.
7. Sugiura K, Miyake T, Taniguchi Y et al. Identification of novel non-insulin-dependent diabetes mellitus susceptibility loci in the Otsuka Long-Evans Tokushima fatty rat by MQM-mapping method. Mamm. Genome 1999; 10: 1126-31.
8. Tanomura H, Taniguchi Y, Muramatsu Y et al. A congenic strain (F344.OLETF-Imfm) displays the existence of intramuscular fat accumulation QTL on rat chromosome 1. Exp. Anim. 2003; 52: 303-8.
9. Watanabe TK, Okuno S, Ono T et al. Single-allele correction of the Dmo1 locus in congenic animals substantially attenuates obesity, dyslipidaemia and diabetes phenotypes of the OLETF rat. Clin. Exp. Pharmacol. Physiol. 2001; 28: 28-42.
10. Okuno S, Watanabe TK, Ono T et al. Effects of Dmo1 on obesity, dyslipidaemia and hyperglycaemia in the Otsuka Long Evans Tokushima Fatty strain. Genet Res. 2001; 77: 183-90.
11. Okuno S, Kondo M, Yamasaki Y et al. Substitution of Dmo1 with normal alleles results in decreased manifestation of diabetes in OLETF rats. Diabetes Obes. Metab. 2002; 4: 309-18.
12. Watanabe TK, Okuno S, Yamasaki Y et al. A < 1.7 cM interval is responsible for Dmo1 obesity phenotypes in OLETF rats. Clin. Exp. Pharmacol. Physiol. 2004; 31: 110-12.
13. Watanabe TK, Bihoreau MT, McCarthy LC et al. A radiation hybrid map of the rat genome containing 5255 markers. Nat. Genet. 1999b; 22: 27-36.
14. Watanabe TK, Ono T, Okuno S et al. Characterization of newly developed SSLP markers of rat. Mamm. Genome 2000; 11: 300-5.
15. Van Ooijen JW, Maliepaard C. MapQTL™ Version 3.0: Software for the Calculation of QTL Position on Genetics Maps. DLO-Centre for Plant Breeding and Reproduction Research, Wageningen, The Netherlands. 1996.
16. Osoegawa K, Zhu B, Shu CL et al. BAC resources for the rat genome project. Genome Res. 2004; 14: 780-5.
17. Dracopoli NC, Haines JL, Korf BR. Current Protocols in Human Genetics. John Wiley & Sons, New York. 1994.
18. Hinuma S, Habata Y, Fujii R et al. A prolactin-releasing peptide in the brain. Nature 1998; 393: 272-6.
19. Fujii R, Fukusumi S, Hosoya M et al. Tissue distribution of prolactin-releasing peptide (PrRP) and its receptor. Regul. Pept. 1999; 83: 1-10.
20. Samson WK, Resch ZT, Murphy TC. A novel action of the newly described prolactin-releasing peptides: Cardiovascular regulation. Brain Res. 2000; 858: 19-25.
21. Taylor MM, Samson WK. The prolactin releasing peptides: RF-amide peptides. Cell. Mol. Life Sci. 2001; 58: 1206-15.
22. Lawrence CB, Celsi F, Brennand J, Luckman SM. Alternative role for prolactin-releasing peptide in the regulation of food intake. Nat. Neurosci. 2000; 3: 645-6.
23. Lawrence CB, Ellacott KL, Luckman SM. PRL-releasing peptide reduces food intake and may mediate satiety signaling. Endocrinology 2002; 143: 360-7.
24. Ellacott KL, Lawrence CB, Rothwell NJ, Luckman SM. PRL-releasing peptide interacts with leptin to reduce food intake and body weight. Endocrinology 2002; 143: 368-74.
25. Lawrence CB, Liu YL, Stock MJ, Luckman SM. Anorectic actions of prolactin-releasing peptide are mediated by corticotropin-releasing hormone receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004; 286: R101-7.
26. Engstrom M, Brandt A, Wurster S, Savola JM, Panula P. Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors. J. Pharmacol. Exp. Ther. 2003; 305: 825-32.
27. Gu W, Geddes BJ, Zhang C, Foley KP, Stricker-Krongrad A. The prolactin-releasing peptide receptor (GPRlO) regulates body weight homeostasis in mice. J. Mol. Neurosci. 2004; 22: 93-103.
28. Vergoni AV, Watanobe H, Guidetti G, Savino G, Bertolini A, Schioth HB. Effect of repeated administration of prolactin releasing peptide on feeding behavior in rats. Brain Res. 2002; 955: 207-13.
29. Ellacott KL, Lawrence CB, Pritchard LE, Luckman SM. Repeated administration of the anorectic factor prolactin-releasing peptide leads to tolerance to its effects on energy homeostasis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003; 285: R1005-10.
30. Seal LJ, Small CJ, Dhillo WS et al. PRL-releasing peptide inhibits food intake in male rats via the dorsomedial hypothalamic nucleus and not the paraventricular hypothalamic nucleus. Endocrinology 2003; 142: 4236-43.
31. Tanomura H, Miyake T, Taniguchi Y et al. Detection of a quantitative trait locus for intramuscular fat accumulation using the OLETF rat. J. Vet. Med. Sci. 2002; 64: 45-50.
32. Takiguchi S, Takata Y, Funakoshi A et al. Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene 1997; 197: 169-75.
33. Beglinger C. Overview. Cholecystokinin and eating. Curr. Opin. Invest. Drugs 2002; 3: 587-8.
34. Beinfeld MC. An introduction to neuronal cholecystokinin. Peptides 2001; 22: 1197-200.
35. Lee GS, Han JB, Shin MK et al. Enhancement of electroacupuncture-induced analgesic effect in cholecystokinin-A receptor deficient rats. Brain Res. Bull. 2003; 62: 161-4.
36. Sei M, Sei H, Shima K. Spontaneous activity, sleep, and body temperature in rats lacking the CCK-A receptor. Physiol. Behav. 1999; 68: 25-9.
37. Feifel D, Priebe K, Shilling PD. Startle and sensorimotor gating in rats lacking CCK-A receptors. Neuropsychopharmacology 2001; 24: 663-70.
38. Moralejo DH, Ogino T, Kose H, Yamada T, Matsumoto K. Genetic verification of the role of CCK-AR in pancreatic proliferation and blood glucose and insulin regulation using a congenic rat carrying CCK-AR null allele. Res. Commun. Mol. Pathol. Pharmacol. 2001; 109: 259-74.
39. Kose H, Moralejo DH, Ogino T, Mizuno A, Yamada T, Matsumoto K. Examination of OLETF-derived non-insulin-dependent diabetes mellitus QTL by construction of a series of congenic rats. Mamm. Genome 2002; 13: 558-62.